Trial Profile

A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Artesunate (Primary)
Indications Vulvar dysplasia; Vulvar intraepithelial neoplasia
Focus Adverse reactions; Proof of concept
Acronyms ART-VIN

Most Recent Events

04 Dec 2024 Status changed from active, no longer recruiting to completed.
30 Oct 2024 Planned End Date changed from 31 Oct 2024 to 5 Dec 2024.
31 Oct 2022 Planned End Date changed from 31 Oct 2022 to 31 Oct 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com